Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients.

被引：0
|
作者：
Nadauld, Lincoln
Van Hummelen, Paul
Xia, Li Charlie
Day, Kenneth
Lee, Hojoon
Bell, John
Grimes, Susan M.
Kubit, Matt
Miller, Mickey
Shin, Giwon
Wood, Christina
Greer, Stephanie
Escobar, Helaman
Haslem, Derrick S.
Ji, Hanlee
机构：
[1] Intermt Precis Genom, St George, UT USA
[2] Stanford Sch Med, Palo Alto, CA USA
[3] Stanford Genome Technol Ctr, Palo Alto, CA USA
[4] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[5] Intermt Healthcare, Intermt Precis Genom, St George, UT USA
[6] Intermt Healthcare, Murray, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15588
引用
收藏
页数：1
相关论文
共 50 条
  • [41] High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival
    Wang, Qingqing
    Ni, Qichao
    Wang, Xudong
    Zhu, Huijun
    Wang, Zhiwei
    Huang, Jianfei
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 9
  • [42] High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival
    Qingqing Wang
    Qichao Ni
    Xudong Wang
    Huijun Zhu
    Zhiwei Wang
    Jianfei Huang
    Medical Oncology, 2015, 32
  • [43] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [44] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Dong, Hua-Jie
    Fang, Cheng
    Wang, Li
    Fan, Lei
    Xu, Ji
    Wu, Jia-Zhu
    Lu, Ting-Xun
    Li, Jian-Yong
    Xu, Wei
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [45] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Hua-Jie Dong
    Cheng Fang
    Li Wang
    Lei Fan
    Ji Xu
    Jia-Zhu Wu
    Ting-Xun Lu
    Jian-Yong Li
    Wei Xu
    Medical Oncology, 2014, 31
  • [46] High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients
    Cho, Sung-Yup
    Park, Changho
    Na, Deukchae
    Han, Jee Yun
    Lee, Jieun
    Park, Ok-Kyoung
    Zhang, Chengsheng
    Sung, Chang Ohk
    Moon, Hyo Eun
    Kim, Yona
    Kim, Jeong Hoon
    Kim, Jong Jae
    Khang, Shin Kwang
    Nam, Do-Hyun
    Choi, Jung Won
    Suh, Yeon-Lim
    Kim, Dong Gyu
    Park, Sung Hye
    Youn, Hyewon
    Yun, Kyuson
    Kim, Jong-Il
    Lee, Charles
    Paek, Sun Ha
    Park, Hansoo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e317 - e317
  • [47] High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients
    Sung-Yup Cho
    Changho Park
    Deukchae Na
    Jee Yun Han
    Jieun Lee
    Ok-Kyoung Park
    Chengsheng Zhang
    Chang Ohk Sung
    Hyo Eun Moon
    Yona Kim
    Jeong Hoon Kim
    Jong Jae Kim
    Shin Kwang Khang
    Do-Hyun Nam
    Jung Won Choi
    Yeon-Lim Suh
    Dong Gyu Kim
    Sung Hye Park
    Hyewon Youn
    Kyuson Yun
    Jong-Il Kim
    Charles Lee
    Sun Ha Paek
    Hansoo Park
    Experimental & Molecular Medicine, 2017, 49 : e317 - e317
  • [48] TP53 mutations and loss of heterozygosity of chromosome 17 in colorectal tumors
    Yamamoto, L
    Lopes, AA
    HarbGama, A
    Nagai, MA
    BRAZILIAN JOURNAL OF GENETICS, 1996, 19 (04): : 647 - 653
  • [49] Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
    van der Sijde, Fleur
    Azmani, Zakia
    Besselink, Marc G.
    Bonsing, Bert A.
    de Groot, Jan Willem B.
    Groot Koerkamp, Bas
    Haberkorn, Brigitte C. M.
    Homs, Marjolein Y. V.
    van IJcken, Wilfred F. J.
    Janssen, Quisette P.
    Lolkema, Martijn P.
    Luelmo, Saskia A. C.
    Mekenkamp, Leonie J. M.
    Mustafa, Dana A. M.
    van Schaik, Ron H. N.
    Wilmink, Johanna W.
    Vietsch, Eveline E.
    van Eijck, Casper H. J.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [50] TP53 gene mutations as a prognostic marker for PSA progression in early stage prostate cancer
    Sachs, MD
    Schlechte, H
    Schiemenz, K
    Lenk, SV
    Schnorr, D
    Rudolph, BD
    Loening, SA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 282 - 282
12345